Arkolith/Insider Trading/INDP/Form 4

Sassi Nir

Chief Financial OfficerIndaptus Therapeutics, Inc. (INDP) · full profile →Form 4 · filed Apr 11, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
7
0 non-derivative · 7 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 10, 2025Disposed to issuer(D)1K$0.07$880
Apr 10, 2025Disposed to issuer(D)1K$0.07$790
Apr 10, 2025Disposed to issuer(D)3K$0.07$1750
Apr 10, 2025Disposed to issuer(D)500$0.07$350
Apr 10, 2025Disposed to issuer(D)500$0.07$350
Apr 10, 2025Disposed to issuer(D)41$0.07$30
Apr 10, 2025Disposed to issuer(D)1K$0.07$790

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001641172-25-003826) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML